Abvc Biopharma ABVC
NASDAQ ABVC
$0.98 +0.01 (+0.64%)
At close: Sep 10, 2026 · 4:00 PM EDT

Abvc Biopharma (ABVC) Preferred Shares (2010 - 2015)

Abvc Biopharma's (ABVC) quarterly Preferred Shares came in at $1.0 in Q3 2015, little changed on a YoY basis from $1.0 in Q3 2014, and down 100.0% quarter-over-quarter from $10.0 million in Q4 2014.

Analysis

Abvc Biopharma (ABVC) Preferred Shares (2010 - 2015) Analysis & Trends

Abvc Biopharma (ABVC) has reported Preferred Shares for 6 consecutive years, with $1.0 the latest figure, recorded in Q3 2015.

  • For the quarter ending Q3 2015, Preferred Shares changed 0.0% year-over-year to $1.0; the trailing twelve-month figure through Sep 2015 stood at $1.0 (changed 0.0% YoY), and the FY2015 full-year result was $1.0, down 100.0% from the prior year.
  • Preferred Shares fell to $1.0 in Q3 2015 per ABVC's latest filing, from $10.0 million in the prior quarter.
  • Across five years, Preferred Shares topped out at $10.0 million in Q3 2011 and bottomed at $1.0 in Q2 2012.
  • Historically, Preferred Shares has averaged $4.5 million across 5 years, with a median of $7.0 in 2011.
  • The sharpest annual moves came in 2011 and 2012: Preferred Shares surged 249999900.0% in 2011, then slumped 50.0% in 2012.
  • Over 5 years, Preferred Shares stood at $7.0 in 2011, then jumped by 142857042.86% to $10.0 million in 2012, then changed by 0.0% to $10.0 million in 2013, then changed by 0.0% to $10.0 million in 2014, then tumbled by 100.0% to $1.0 in 2015.
  • According to Business Quant data, Preferred Shares over the past three periods registered $1.0, $10.0 million, and $1.0 for Q3 2015, Q4 2014, and Q3 2014 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Abvc Biopharma 25.56 Mn 25.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 1.00
Dec 31, 2014 10.00 Mn
Sep 30, 2014 1.00
Mar 31, 2013 10.00 Mn
Dec 31, 2012 10.00 Mn
Sep 30, 2012 10.00 Mn
Jun 30, 2012 1.00
Mar 31, 2012 7.00
Dec 31, 2011 7.00
Sep 30, 2011 10.00 Mn
Jun 30, 2011 2.00
Sep 30, 2010 4.00